The true cost of not exhibiting at AHA Scientific Sessions
Missing out means lost leads, reduced visibility and missed influence
Exhibiting at AHA Scientific Sessions is an investment — but choosing not to participate carries its own costs. With more than 10,400 professional attendees anticipated, the #AHA25 audience includes cardiovascular decision-makers, researchers and clinicians who influence patient care and purchasing decisions.
Lead generation
The exhibit hall is where conversations begin. By not exhibiting, companies miss the chance to connect directly with new contacts, qualify leads on the spot, and follow up with decision-makers who are actively seeking solutions.
Brand visibility
At AHA Scientific Sessions, exhibitors are seen multiple times across print, digital and on-site touchpoints. Companies that skip the meeting risk losing visibility to competitors who showcase their presence consistently before, during and after the event.
Educational influence
Scientific Sessions is where new data and emerging science shape the specialty. Exhibitors who are present can align their messaging with this momentum through booth conversations, sponsored education and digital promotions. Without that presence, a company’s voice may be absent from critical conversations.
Networking opportunities
Beyond scheduled sessions, many partnerships are formed in informal conversations at the booth, in lounges or during networking events. Companies that don’t exhibit forgo these organic, face-to-face interactions that can be difficult to replicate in other settings.
Choosing not to exhibit may save budget in the short term, but the long-term costs — lost leads, reduced visibility and missed influence — can be far greater.
![Faq [converted]](https://img.hub.heart.org/mindful/ascend/workspaces/default/uploads/2025/08/faq-converted.dktIZ9LFru.png?auto=format%2Ccompress&bg=fff&fill-color=fff&fit=fill&h=191&q=70&w=340)
